Medical, nutritional and technological properties of lactulose. An update

European Journal of Nutrition

Volumn 41, Issue SUPPL. 1, 2002, Pages 17-25

  Schumann, Christian ^a  

^a Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Constipation; Feed; Lactulose; Milk; Nutrition; Portosystemic encephalopathy; Prebiotic; Prevention

Indexed keywords

ACETIC ACID; AZO REDUCTASE; BACTERIAL ENZYME; BETA GLUCURONIDASE; BUTYRIC ACID; DISACCHARIDE; ENDOTOXIN; FOOD ADDITIVE; FRUCTOSE; GALACTOSE; GLUCOSE; INSULIN; LACTIC ACID; LACTOSE; LACTULOSE; NITROREDUCTASE; OXYGENASE; PROPIONIC ACID; TAGATOSE; UREASE; YOGHURT;

ARTICLE; BACTERIAL GROWTH; BIFIDOBACTERIUM; CLOSTRIDIUM; CONSTIPATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; FOOD INDUSTRY; GLUCOSE BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION PREVENTION; INSULIN BLOOD LEVEL; LACTIC ACID BACTERIUM; NUTRITION; PHARMACODYNAMICS; SALMONELLA; TECHNOLOGY;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIA; CLOSTRIDIUM; SALMONELLA;

EID: 0036871554     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-002-1103-6     Document Type: Article

References (73)

1. Montgomery EM, Hudson CS (1930) Relationship between rotary power and structure in the sugar group XXVII. Synthesis of a new saccharide ketose (lactulose) from lactose. J Am Chem Soc 52:2101-2106
2. Battermann W (1997) Lactulose powder - main technological properties and its relevance in functional food. Internal Report Solvay Deutschland GmbH (Report no. AWTLAC 12.041.97)
3. Kitler ME, Luginbühl M, Lang O, Wuhl F, Wyss A, Lebek G (1992) Lactitol and lactulose. An in vivo and in vitro comparison of their effect on the human intestianl flora. Drug Invest 4:73-82
4. Ballongue J, Crociani J, Grill JP (1995) In vitro study of the effect of lactulose and lactitol on growth and metabolism of intestinal bacteria. Gut 37 (Suppl 2):A48
5. Ballongue J, Schumann C, Quignon P (1997) Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand J Gastroenterol 32 (Suppl 222):41-44
6. Pontes FA, Silva AT, Cruz AC (1995) Colonic tansit time and the effect of lactulose and lactitol in hospitalised patients. Europ J Gastroenterol Hepatol 7:441-445
7. Wang X, Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373-380
8. Petuely F (1958) Der Bifidusfaktor. Dt Med Wschr 82:1957-1960
9. MacGillivray PC, Finlay HVL, Binns TB (1959) Use of lactulose to create a preponderance of lactobacilli in the intestine of bottle-fed infants. Scottish Med J 4:182-189
10. Mayerhofer F, Petuely F (1959) Untersuchungen zur Regulation der Darmträgheit des Erwachsenen mit Hilfe der Lactulose (Bifidus-Faktor). Wien Klin Wochenschr 71:865-869
11. Blei AT, Cordoba J (2001) Hepatic encephalopathy. Am J Gastroenterol 96:1968-1976
12. Bircher J, Müller J, Guggenheim P, Haemmerli UP (1966) Treatment of chronic portal systemic encephalopathy with lactulose. Lancet 1:890-892
13. Conn HO, Leevy CM, Vlahecevic ZR, et al. (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double-blind controlled trial. Gastroenterology 72:573-583
14. Conn HO (1994) The theoretic therapy of hepatic encephalopathy. In: Conn HO, Bircher J (eds) Hepatic Encephalopathies - Syndromes and Therapies. Medi-Ed Press, Bloomington, pp 135-147
15. Soeters PB, Van Leeuwen PAM (1986) Ammoniak- und Glutaminstoffwechsel des Darms. Einfluß von Lactulose und Neomycin. Infusionsther 13:186-190
16. Westphal G (1992) Zur Ernährungsphysiologie und -toxikologie von MAILLARD-Reaktionsprodukten. 1. Reaktionsmechanismen in vitro und in vivo. Ernährungs-Umschau 39:450-452
17. Hoffmann K (1975) Behandlung von gesunden Salmonellen-Ausscheidern mit Lactulose. Dtsch Med Wochenschr 100:1429-1431
18. Baglioni A, Dubini F (1976) Lattulosio: valutazione tossicologica (Lactulose, a toxicological evaluation). Bollettino Chemico Farmacentico 115:596-606
19. Conn HO, Bircher J (1994) Adverse reactions and side effects of lactulose and related agents. In: Conn HO, Bircher J (eds) Hepatic Encephalopathy. Syndromes and Therapies. Bloomington, Illinois: Medi-Ed Press, pp 399-412
20. Nunez M, Robinson BE (1991) Management of constipation in the older patient. J Florida Med Ass 78:829-831
21. Baskaran V, Narasimhamurthy K, Nagendra R, Lokesh BR (1999) Safety evaluation of lactulose syrup in rats. J Food Sci Techn 36:355-357
22. Huchzermeyer H, Schumann C (1997) Lactulose - a multifaceted substance. Z Gastroenterol 35:945-955
23. Ebner N (1973) Milchzucker und Milchzuckerderivate (Laevolac®) in der Behandlung des endogenen Faktors der Parodontopathien. Österr Zeitschr Stomat 70 (9):317-324
24. Conte D, Bardella MT, Bernardi M, et al. (1977) Hypocholesterinemic effect of lactulose in man. Panminerva Med 19 (1):1-4
25. Rotstein OD, Kay RM, Wayman M (1981) Prevention of cholesterol gallstones by lignin and lactulose in the hamster. Gastroenterology 81:1098-1103
26. Josimovic IB (1979) Die Verhütung des Dickdarmkrebses mit Lactulose. Krebs geschehen 6:175-178
27. Thornton JR, Heaton KW (1981) Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J 282 (6269):1018-1020
28. Van Berge Henegouwen GP, Van der Werf SDJ, Ruben AT (1986) Effect of lactulose on biliary lipid composition. J Hepatology 3:328-332
29. Van Berge Henegouwen GP, van der Werf SDJ, Ruben AT (1987) Effect of long term lactulose ingestion on secondary bile salt metabolism in man: potential protective effect of lactulose in colonic carcinogenesis. Gut 28:675-680
30. Ronchi M, Simoni P, Mazella G, et al. (1987) Effect of lactulose administration on bile acid metabolism and biliary lipid secretion in man. Gastroenterology 92 (5):1768
31. Liao W, Cui XS, Yin XY, Floren CH (1994) Lactulose - a potential drug for the treatment of inflammatory bowel disease. Med Hypothesis 43:234-238
32. Kennedy RJ, Kirk SJ, Gardiner KR (2000) Promotion of a favorable gut flora in inflammatory bowel disease. J Parenteral Enteral Nutr 24:189-195
33. Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M, Ponz de Leon M (1993) Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 36:227-234
34. Reddy BS, Rivenson A (1993) Inhibitory effect of Bifidobactierum longum on colon, mammary and liver carcinogenesis indused by 2-amino-3-methylimidazo (4,5-f) quinolone, a food mutagen. Cancer Research 53:3914-3918
35. Rowland IR, Bearne CA, Fischer R, Pool-Zobel BL (1996) The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats. Nutr Cancer 26:37-47
36. Schumann C (1997) Die immunologischen Effekte der Lactulose. Notabene medici 27:288-290
37. Kalliomäki M, Salminen S, Arvilommi H, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076-1079
38. Rinne M, Kirjavainen P, Salminen S, Isolauri E (2002) Lactulose - any clinical benefits beyond constipation relief? A pilot study in infants with allergic symptoms. Poster publication. American College of Allergy, Asthma and Immunology Meeting: Adverse reactions to bovine proteins, Milan, 13-15 December, 2001. Submitted
39. Liehr H, Heine WD (1981) Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously. Hepato-Gastroenterol 28:296-298
40. Greve JWM, Gouma DJ, Leeuwen PAMv, Buurman WA (1990) Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study. Gut 31:198-203
41. Liehr H, Englisch G, Rasenack U (1980) Lactulose - a drug with antiendotoxin effect. Hepato-Gastroenterology 27: 356-360
42. Pain JA, Cahill CJ, Gilbert JM, Johnson CD, Trapnell JE, Bailey ME (1991) Prevention of postoperative dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose. Br J Surg 78:467-469
43. Özçelik MF, Pekmezci S, Altinli E, Eroglu C, Göksel S, Göksoy E (1997) Lactulose to prevent translocation in biliary obstruction. Dig Surg 14:267-271
44. Kramer HJ (1988) Therapie des hepatorenalen Syndroms. Deut med Wschr 113:561-564
45. Mack DR, Flick JA, Durie PR, et al. (1992) Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction. J Pediatr 120:696-701
46. Tabatabaie T, Kotake Y, Wallis G, et al. (1997) Spintrapping agent phenyl-Ntert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus. FEBS Lett 407:148-152
47. Yelich MR, Schieber CK, Umporowicz DM, et al. (1992) Polymyxin-B suppresses endotoxin-induced insulin hypersecretion in pancreatic islets. Circ Shock 38:85-90
48. Liao W, Florin CH (1995) Endotoxin, Cytokines and Hyperlipidemia. Scand J Gastroenterol 28:97-103
49. McCutcheon J, Fulton JD (1989) Lowered prevalence of infection with Lactulose therapy in patients in continuing hospital care. J Hosp Infect 13:81-86
50. Mack DJ, Smart L, Girdwood A, Scott PJW, Fulton JD, Erwin L (1993) Infection prophylaxis with Lactulose. Age & Ageing 22(Suppl 2):8
51. Baumjohann H, Schumann C, Rentz B (1991) Rezidivierende Vaginal- und Darmmykosen - mit Lactulose zu behandeln? Notabene medici 6/7:273-275
52. Tomoda T, Nakano Y, Kageyama T (1988) Intestinal Candida overgrowth and Candida infection in patients with leukemia: effect of Bifidobacterium administration. Bifidobacteria Microflora 7:71-74
53. Bernhardt H, Knoke M (1997) Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol 32 (Suppl 222):102-106
54. Dunker-Schmidt C, Schumann C (1998) Lactulose-Pulver - wirksam bei Candida-Mykosen des Darms? Ärztliche Forschung 45:ISSN 0001-9496
55. Genovese S, Riccardi G, Rivellese AA (1993) Lactulose improves blood glucose response to an oral glucose test in non-insulin dependent diabetic patients. DNM 5:295-297
56. Bianchi GP, De Mitri MS, Bugianesi E, Abbiati R, Fabbri A, Marchesini G (1994) Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity. Ital J Gastroenterol 26:174-178
57. Hosaka H, Tokunaga K, Sakumoto I (1972) The influence of lactulose on intestinal absorption. Gastroenterol Jpn 7:316-317
58. Cornell RP (1985) Endogenous gut-derived bacterial endotoxin tonically primes pancreatic secretion of insulin in normal rats. Diabetes 34:1253-1259
59. Van den Heuvel EGHM, Muijs T, van Dokkum W, Schaafsma G (1999) Lactulose stimulates calcium absorption in postmenopausal women. J Bone Mineral Res 14:1211-1216
60. Brommage R, Juillerat MA, Jost R (1991) Influence of casein phosphopeptides and lactulose on intestinal calcium absorption in adult female rats. Lait 71:173-180
61. Igarashi C, Ezawa I (1991) Effects of whey calcium and lactulose on the strength of bone in ovariectomized osteoporosis model rats. Pharmacometrics (Jpn) 42(3):245-254
62. Van den Heuvel EGHM, Weidauer T (1999) Role of the non-digestible carbohydrate lactulose in the absorption of calcium. Med Sci Monit 5:1231-1237
63. Fries R, et al. (2000) Untersuchungen zur Salmonellensituation in Schweinemastbestanden. Maßnahmen zur Reduzierung der Salmonellen in Schweinebeständen. Forschungsberichte der Universität Bonn, Landwirtschaftliche Fakultät, vol. 79 (ISSN 0943-9684)
64. Geier H, Klostermeyer H (1983) Formation of lactulose during heat treatment of milk. Milchwissenschaft 38:475-477
65. Engel CE, Olinger PM (1979) High pressure liquid chromatographic determination of saccharides in corn syrups: collaborative study. J Assoc of Anal Chem 62:527-532
66. Laker MF (1979) Estimation of disaccharides in plasma and urine by gasliquid chromatography. J Chromat 163: 9-18
67. Catassi C, Bonucci A, Coppa GV, et al. (1995) Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr 21:383-386
68. Bao Y, Silva TM, Guerrant RL, et al. (1996) Direct analysis of mannitol, lactulose and glucose in urine samples by high-performance anion-exchange chromatography with pulse amperometric detection. Clinical evaluation of intestinal permeability in human immuno deficiency virus infection. J Chromatogr Biomed Appl 685:105-112
69. Marsilio R, D'Antiga L, Zancan L, et al. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem 44:1685-1691
70. Cox MA, Iqbal TH, Cooper BT, Lewis KO (1997) An analytical method for the quantitation of mannitol and disaccharides in serum: a potentially useful technique in measuring small intestinal permeability in vivo. Clin Chim Acta 263:197-205
71. Sekine Y, Hall EAH (1998) A lactulose sensor based on coupled enzyme reactions with a ring electrode fabricated from tetrathiafulvalen-tetracyanoquinodimethane. Biosensors Bioelectronics 13:995-1005
72. Clawin-Rädecker I, Kuhlmann B, Weiß G, et al. (1992) Lactulosegehalt in UHT-Milchen des Handels. Kiel Milchwirtsch Forschungsber 44:129-141 (Engl. and French summary)
73. Villamiel M, Corzo N (1998) Lactulose formation during batch microwave treatment of different types of dairy products. Milchwissenschaft 53:487-490